In this Friday's PCT Grand Rounds, Edward Qian of Vanderbilt University will present "The Effect of Antibiotic Choice on Renal Outcomes: The ACORN Trial."
The Grand Rounds session will be held on Friday, March 15, 2024, at 1:00 pm eastern.
The ACORN trial compared the effects of cefepime vs piperacillin-tazobactam on the incidence of acute kidney injury among acutely ill adults. In this innovative study, randomization of eligible patients occurred at the prescriber level within the electronic medical record.
Qian, the principal investigator for ACORN, is an assistant professor of medicine and the assistant director for quality and education of the medical ICU at the Vanderbilt University Medical Center.